Evaluation of Anticholinergic Treatment Response and Predictive Factors in Pediatric Overactive Bladder
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- Number of patients with drug related adverse effects
研究概览
简要总结
This study aims to evaluate the efficacy and adverse effect incidence of three different anticholinergics (oxybutinin, propiverine, and tolterodine) that are used in children with overactive bladder.
详细描述
A total of approximately 150 patients with overactive bladder will be evaluated retrospectively. Clinical and demographic data and voiding diaries of these patients will be evaluated. For this purpose, patients will be divided into mainly three groups according to the anticholinergic agent used.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 5 Years 至 17 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients diagnosed with overactive bladder
- •Patients treated with an anticholinergic
排除标准
- •Presence of anatomical or neurological problems
- •Patients with missing data
研究组 & 干预措施
Oxybutynin
Patients treated with oxybutynin
干预措施: Oxybutynin Cl (Drug)
Propiverine
Patients treated with propiverine
干预措施: propiverine (Drug)
Tolterodine
Patients treated with tolterodine
干预措施: Tolterodine (Drug)
结局指标
主要结局
Number of patients with drug related adverse effects
时间窗: 1 month
Number of patients treated with anticholinergic
时间窗: 6 months
次要结局
未报告次要终点
研究者
Furkan Adem Canbaz
Medical doctor
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital